Breyer Capital

What Breyer Capital does

Breyer Capital is a privately-held, family-controlled venture capital and private equity firm founded by Jim Breyer that invests across multiple technology sectors with anchor themes in artificial intelligence, healthcare and life sciences, consumer software, media and gaming, fintech, enterprise and data, security and defense technology, and climate. The firm positions itself as a long-term, high-conviction investor that commits capital at inception and supports portfolio companies through institutional scale, sourcing opportunities primarily through founder networks, university partnerships, and reputation-driven deal flow rather than competitive auctions.

The firm's business model follows the standard venture capital structure of charging management fees on committed capital and earning carried interest from successful portfolio exits. Notable historical investments include Facebook (lead investor in the 2005 first institutional round, returning over 100x), Etsy, Legendary, Marvel Entertainment, Spotify, 21st Century Fox, and Circle, with more recent investments spanning AI-driven medicine (Pathway Labs, ParcelBio, Soley Therapeutics, OpenEvidence, Hippocratic AI, Ambience Healthcare), fintech and crypto infrastructure (Circle, Catena Labs, EigenLayer, Chia, ZenBusiness), consumer (Grammarly, Headspace, Epic Games, Zepto, Taager), and enterprise AI/quantum (Sandbox AQ, Shield AI). The firm operates from Austin, Texas (headquarters since 2020) and Menlo Park, California, with a small core team supplemented by partners Daniel and Ted Breyer, Partner Morgan Cheatham (Head of Healthcare and Life Sciences), and venture advisors including former IBM CEO Samuel Palmisano and physician-scientist Dr. Bret Bostwick.

The firm has increasingly emphasized healthcare AI as a core thesis, supported by the strategic partnership with Harvard Medical School's AI in Medicine (AIM) PhD track and the appointment of clinically-trained venture advisors. Geographic reach extends across North America, Europe (Sweden), the Middle East (Saudi Arabia, UAE, Egypt), Asia (India), and Africa (Kenya) through portfolio company operations and co-investor networks, though deployment remains concentrated in U.S.-headquartered companies.

Name

Breyer Capital

Legal name

Breyer Capital L.L.C.

Website

https://breyercapital.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Breyer Capital is a family-controlled venture capital firm founded by Jim Breyer that invests across AI/healthcare, consumer software, fintech, enterprise data, security, and climate sectors, sourcing deals through founder networks and university partnerships with patient capital.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Venture capital investing
• Private equity
• Early-stage funding
• Technology investments
• Healthcare investments

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Management Fees: Standard VC management fee structure charged on committed capital
2. Carried Interest: Performance-based carried interest from successful portfolio company exits and realizations

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Breyer Capital is a venture capital and private equity firm that invests patient capital in early-stage and growth-stage technology and healthcare companies alongside strategic guidance, board participation, and hands-on operational support. The firm's portfolio spans AI and AI health, quantum, consumer software, media and gaming, fintech, enterprise and data, security and defense tech, and climate sectors, with capital deployed from inception through institutional scale.

Product overview

Breyer Capital is a premier venture capital firm focused on catalyzing high-impact entrepreneurs. The firm does not offer a unified product platform; rather, it provides investment capital, strategic guidance, and partnership support to early-stage companies. Breyer Capital's investment strategy centers on artificial intelligence and machine learning, healthcare and life sciences, consumer software, media and gaming, fintech, enterprise and data technologies, security and defense technology, and climate solutions. The firm partners with founders at inception and through growth stages, offering patient capital and hands-on support across portfolio companies.

Differentiator

Problem solved

Functional benefit

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Dr. Bret BostwickcoreStrategic or Co-development Partner · 19 December 2025Dr. Bret Bostwick, physician-scientist with Alnylam Pharmaceuticals experience, appointed as Venture Advisor to strengthen healthcare and life sciences investment platform
• Harvard Medical SchoolcoreStrategic or Co-development Partner · 4 March 2025Breyer Capital made significant investment to support Harvard Medical School's AI in Medicine (AIM) PhD track, reinforcing its leadership in healthcare AI and commitment to education and innovation

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bessemer Venture Partners: Long-standing venture firm with deep healthcare/life sciences franchise that incubated Morgan Cheatham before he joined Breyer. Directly comparable in stage, healthcare focus, and B2B/enterprise orientation.
• General Catalyst: Multi-stage venture and transformation firm with substantial healthcare and fintech exposure. Comparable in breadth and stage; co-invested with Breyer in Catena Labs.
• Khosla Ventures: High-conviction, founder-first venture firm with strong AI and healthcare investing practices. Comparable thesis around transformative technology and willingness to invest at inception.
• Greylock Partners: Silicon Valley venture firm with comparable enterprise and consumer focus, and similar concentration on early-stage, high-conviction founder partnerships.
• Founders Fund: Founder-led venture firm investing across deeptech, healthcare, and frontier technology with long-duration capital philosophy comparable to Breyer's patient-capital stance.
• Andreessen Horowitz (a16z): Premier Silicon Valley venture capital firm investing across stages and sectors. Most direct peer to Breyer Capital in scale, sector breadth (consumer, enterprise, fintech, healthcare/AI), and LP-backed fund model; co-invested with Breyer in Catena Labs.
• Accel: Early-stage venture capital firm with similar consumer/internet and enterprise focus. Closely comparable stage and sector profile to Breyer Capital's portfolio.

Broad incumbents

• New Enterprise Associates (NEA): Large diversified venture firm with deep healthcare and technology franchises. Comparable sector breadth to Breyer but materially larger scale and longer fund history.
• Insight Partners: Large venture and growth firm with concentrated software and healthcare exposure. Comparable AI/healthcare thesis but skews toward growth-stage versus Breyer's earlier-stage inception investing.
• Sequoia Capital: Largest and most established venture capital firm with comparable early-stage concentration in tech, healthcare, and fintech. Highly comparable to Breyer in stage and sector, but materially larger AUM and longer fund history.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/jimihendrixlive
• Facebookfacebook.com/timeline
• LinkedInlinkedin.com/company/6613913

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments200 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breyer Capital